![]() |
|
|
Vol. 289, Issue 3, 1480-1486, June 1999
Institut für Pharmakologie und Toxikologie,
Westfälische Wilhelms-Universität Münster, Germany
(J.K., P.B., I.L., S.H., B.L., H.L., F.U.M., T.M., P.N., W.S., U.V.,
J.N.); and Institut für Physiologie, Justus-Liebig
Universität Gie
en, Aulweg 129, Gie
en, Federal Republic of
Germany (T.N., H.M.P.)
| |
Abstract |
|---|
|
|
|---|
In this study, we characterized the effects of the protein phosphatases
type 1 (PP 1) and type 2A (PP 2A) inhibitor cantharidin in endothelial
cells. We identified catalytic subunits of PP 1
, PP 2A
, and PP
2A
immunologically in bovine aortic endothelial cells. Moreover, we
detected mRNAs coding for catalytic subunits of PP 1
, PP 1
, and
PP 2A
by hybridization with specific DNA probes in total RNA from
these cells. Okadaic acid and cantharidin inhibited the
activities of catalytic subunits of PP 1 (okadaic acid, 0.01-1 µM;
cantharidin, 1-100 µM) and PP 2A (okadaic acid, 0.1 nM to 1 µM;
cantharidin, 0.1-100 µM) separated by column chromatography in a
concentration-dependent manner. Moreover, cantharidin (1 µM to 1 mM)
increased the phosphorylation state of endothelial proteins including
the regulatory light chains of myosin without affecting cytosolic
calcium concentrations. Cantharidin (5-100 µM) increased the
permeability of cultured endothelial cells in a time- and
concentration-dependent manner. We suggest that inhibition of PP 1 and
PP 2A activities by cantharidin increases endothelial permeability by
enhancing the phosphorylation state of endothelial regulatory proteins.
Thus, cantharidin might be a useful tool to study the function of
protein phosphatases in endothelial barrier function.
| |
Introduction |
|---|
|
|
|---|
Reversible
protein phosphorylation, mediated by protein kinases and protein
phosphatases (PPs), is an important mechanism used to regulate cellular
function. At least four types of serine/threonine PPs are present in
mammalian tissue: PPs type 1 (PP 1), type 2A (PP 2A), type 2B, and type
2C (Cohen, 1989
; Hunter, 1995
; Shenolikar and Nairn, 1991
; Wera and
Hemmings, 1995
). The availability of cell membrane permeant inhibitors
like okadaic acid (Tachibana et al., 1981
) and cantharidin (Honkanen,
1993
) has facilitated the study of the functional role of PP 1 and PP
2A. Okadaic acid is a polyether fatty acid first isolated from black
sponges (Halichondria okadai). Cantharidin is another
natural toxicant produced by as many as 1500 different species of
blister beetles (Honkanen, 1993
). Using these inhibitors, PPs have
gained interest in recent years as potentially important regulators of
cellular function.
PPs exist in endothelial cells, and their inhibition alters the
phosphorylation state of regulatory proteins. For instance, in bovine
pulmonary artery endothelial cells, inhibition of PP leads to
phosphorylation of the regulatory light chains of myosin (MLC20) (Verin et al., 1995
). Recent data
indicate, however, that thrombin can enhance
MLC20 phosphorylation by inhibition of PP activity (Shasby et al., 1997
). These findings suggest an important regulatory role of PP in endothelial cells. Receptor signals may act
through stimulation or reduction of PP activity. The potential coupling
mechanisms between receptors and intracellular PP are as yet unknown.
Thrombin or histamine increase Ca2+ in human
umbilical vein endothelial cells and increase
MLC20 phosphorylation by activating
Ca2+/calmodulin-dependent myosin light chain
kinase (MLCK) (Garcia et al., 1995
; Shasby et al., 1997
). Others
assumed that thrombin and histamine first elevate cytosolic
Ca2+ and that this Ca2+
rise then triggers the activity of MLCK.
We tested the hypotheses that cantharidin can increase the phosphorylation state of proteins in endothelial cells, can inhibit PP activity in endothelial cells, and can alter endothelial barrier function.
| |
Materials and Methods |
|---|
|
|
|---|
Macromolecule Permeability
Endothelial cells from bovine aorta were isolated as previously
described for porcine aortic endothelial cells (Spahr and Piper, 1990
).
Briefly, bovine endothelial cells were prepared by gentle mechanical
scraping of the intima of the descendent part of bovine aortae.
Harvests of endothelial cells were plated at a density of
106 cells per 100-mm plastic Petri dish. The
cells were cultured at 37°C in medium 199 with Earle's salt
supplemented with 100 IU/ml penicillin G, 100 µg/ml streptomycin, and
20% (v/v) newborn calf serum. Confluent cultures of primary
endothelial cell were trypsinized in PBS composed of 137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, and
8 mM Na2HPO4, at pH 7.4, supplemented with 0.05% (w/v) trypsin, and 0.02% (w/v) EDTA. Cells
were seeded at a density of 7 × 104
cells/cm2 on 24-mm round polycarbonate filters
(pore size, 0.4 µm) for determination of albumin permeability.
Experiments were performed with confluent monolayers 4 days after seeding.
We studied the permeability of the endothelial cell monolayer in a
two-compartment system separated by a filter membrane (Noll et al.,
1996
). Both compartments contained as basal medium modified Tyrode's
solution (150 mM NaCl, 2.7 mM KCl, 1.2 mM
KH2PO4, 1.2 mM
MgSO4, 1 mM CaCl2, and 30 mM HEPES, pH 7.4, 37°C) supplemented with 5% (v/v) newborn calf
serum. There was no hydrostatic pressure gradient between both
compartments. The "luminal" compartment containing the monolayer
had a volume of 2.5 ml, and the "abluminal" had a volume of 13 ml.
The fluid in the abluminal compartment was constantly stirred. Trypan
blue-labeled albumin (60 µM) was added to the luminal compartment.
The appearance of labeled albumin in the abluminal compartment was
continuously monitored by pumping the liquid through a
spectrophotometer (Specord 10; Zeiss, Jena, Germany). Increases in the
concentration of labeled albumin were detected with a time delay of
less than 15 s. The concentration of labeled albumin in the
luminal compartment was determined every 10 min of incubation. It did
not change significantly in the time frame of the experiments. The
albumin flux across the monolayer was determined as described
previously (Siflinger-Birnboim et al., 1987
; Garcia et al., 1996
;
Hempel et al., 1996
).
Experimental Protocol
The basal medium used in incubations was a modified Tyrode's solution (composition as described in Macromolecule Permeability). Macromolecule permeability of the endothelial monolayer, transferred to the incubation chamber, was determined after an initial equilibration period of 20 min. Then, the basal albumin permeability of each monolayer-filter system was determined for another 20 min of incubation. Agents were added as indicated, and the response of albumin permeability was recorded for a further 120 min. The solvent alone (control) did not affect permeability.
Biochemical Studies
Cell Culture.
We obtained bovine aortic endothelial cells by
collagenase digestion as described (Knapp et al., 1997
). Cells grown in
a humidified incubator under an atmosphere of 7.5%
CO2/21% O2 at 37°C
reached confluence within 5 to 7 days forming monolayers with a
"cobblestone" appearance. In addition, we confirmed the nature as
endothelial cells by positive staining with an antibody to factor
VIII-related antigen (data not shown, see Knapp et al., 1997
). We only
used primary endothelial cells or cells of the first passage for the experiments.
Measurement of Cytosolic Calcium ([Ca]i).
Primary bovine aortic endothelial cells were seeded onto 15-mm-diameter
coverslips and used 6 to 7 days later at subconfluent density. Cells
were washed twice with physiological saline solution containing: 145 mM
NaCl, 5.6 mM KCl, 1 mM MgSO4, 2 mM
CaCl2, 20 mM HEPES, 10 mM glucose, pH 7.4, and
then incubated with cell-permeant indo-1-acetoxymethylester (5 µM)
and 0.5% (v/v) of the nonionic surfactant pluronic F-127 [20% in
dimethyl sulfoxide (DMSO); Molecular Probes, Eugene, OR] for 60 min at
25°C. At the end of the loading period, the coverslips were washed
twice with physiological saline solution and maintained an additional
60 min to allow for complete de-esterfication of the indicator at room
temperature. Cells were then placed in a perfusion chamber on the stage
of a modified inverted microscope (Diaphot 200; Nikon, Tokyo, Japan)
and superfused with prewarmed physiological saline solution (0.8 ml/min). All experiments were performed at 25°C.
[Ca]i was recorded from a field of
approximately 20 cells using a dual-emission microfluorescence system
(PTI, Princeton, NJ) as described before (Knapp et al., 1998
). The
ratio of the two emission wavelengths (405 nm and 495 nm) was used as
an index of intracellular free calcium ion concentration. Data
acquisition and processing were supported by software (Felix Version
1.1, PTI) for intracellular calcium measurement.
Phosphorylation Experiments
Labeling of Bovine Aortic Endothelial Cells. Bovine aortic endothelial cells were harvested by trypsin (0.05%)/EDTA (0.02%) solution and washed twice in phosphate-free solution (Na-HEPES buffer) consisting of : 132.0 mM NaCl, 4.8 mM KCl, 1.2 mM MgSO4, 10 mM glucose, 10 mM HEPES, and 2.5 mM sodium pyruvate, pH 7.4, at 37°C. The cells were sedimented by centrifugation (366g, 4°C) for 10 min. Bovine aortic endothelial cells were resuspended in 10 ml of Na-HEPES buffer and incubated with 5 mCi of 32P-labeled orthophosphate for 2 h at 37°C.
Protein Phosphorylation. We added adenosine deaminase (20 U/ml) to avoid interference from endogenous adenosine upon treatment. The drug solution (100 µl) was preincubated at 37°C before mixing with the final cell suspension of bovine aortic endothelial cells (100 µl) and kept at 37°C. Reaction was stopped after 30 min by addition of 100 µl of SDS stop solution consisting of 62.5 mM tris(hydroxymethyl) aminomethane, 10% SDS (w/v), 10% glycerol (v/v), 0.6% DL-dithiothreitol (w/v), and a trace of bromphenol blue, pH adjusted to 6.8.
SDS-Polyacrylamide Gel Electrophoresis and Autoradiography.
Samples were heat treated (95°C), and aliquots of 100 µl
corresponding to 20 to 30 µg of protein were applied to each lane. Gels were run and dried, and incorporated radioactivity was quantitated by PhosphorImager (Molecular Dynamics, Krefeld, Germany) using ImageQuant software as described (Knapp et al., 1998
).
Immunological Identification of the Regulatory Light Chains of Myosin
32P-Labeled endothelial cells were
incubated with cantharidin, okadaic acid, or an appropriate amount of
DMSO as control for 30 min at 37°C. The reaction was stopped, and
samples were subjected to electrophoresis. Separated proteins were
transferred to nitrocellulose membranes and were incubated with
monoclonal antimyosin (light chains, 20 kDa). Proteins binding the
antibody were visualized using alkaline phosphatase-conjugated goat
anti-mouse IgM and color reagents as reported before (Knapp et al.,
1998
).
Immunological Identification of PPs Type 1 and Type 2A
The immunological identification of PP 1 and PP 2A in
endothelial cells was performed according to the method described
recently (Knapp et al., 1998
).
Northern Blotting
Tissues were homogenized using a microdismembrator (B. Braun
Biotech Intl., Melsungen, Germany) in TriStar-Reagent (AGS, Heidelberg, Germany). Total RNA was extracted as published (Knapp et al., 1998
).
First-strand cDNA was synthesized from 1 µg of total RNA from rat
heart as described (Knapp et al., 1998
). Primers based on published rat
cDNA sequences for PP 1
(Barker et al., 1990
), PP 1
(Barker et
al., 1994
), PP 1
(Sasaki et al., 1990
), PP 2A
(Stone et al.,
1988
), and PP 2A
(Hemmings et al., 1988
) were used to generate
subtype-specific probes by reverse transcription-polymerase chain
reaction (RT-PCR).
The primers for PP 1
were 5'-ATGCTGGGGGGGGGTCAC-3' and
5'-CCTTTATTCAAGAGACCAGATGGG-3', for PP 1
5'-CACTGTAAAACCATCCAGCCATTTTG-3' and
5'-TGACAAAATGTCCCACTGACCAGC-3', for PP 1
5'-ACCCGTCCATTCAGA AAGC-3' and 5'-CAAGCTCGCATTTAATAAGTCTG-3', for PP 2A
5'-CCTCTTGTCATCAACAGCCGT G-3' and
5'-GCAGGAAGAACCCACAAAGTG-3' 5'-GGGATCTGTCTT GGCATTAAACC-3' and for
PP 2A
and 5'-CACCAAATAGGATGCAAGCAC TG-3'.
All PCR reactions were carried out as described recently (Knapp et al.,
1998
). Each reaction was subjected to 35 cycles of denaturation (1 min,
94°C), annealing (2 min, 56°C for PP 1
, 56°C for PP 1
,
54°C for PP 1
, 52°C for PP 2A
, and 62°C for PP 2A
), and
extension (2 min, 72°C). To prove identity, these PCR products from
rat cardiac RNA were cycle sequenced and used in Northern blots, which
were performed as reported (Knapp et al., 1998
). Blots were exposed to
PhosphorImager screens and visualized using a PhosphorImager (Molecular
Dynamics, Krefeld, Germany).
Phosphatase Activity
Preparation of Homogenates.
The preparation of homogenates
of endothelial cells was performed according to the method described
recently (Knapp et al., 1998
). The supernatants after centrifugation
are termed homogenate throughout this work. Aliquots of homogenates
were used for determination of phosphatase activity.
Separation of Phosphatases.
The separation was performed as
described (Neumann et al., 1995
; Knapp et al., 1998
). Homogenates were
centrifuged for 30 min at 27,000g (4°C). To the
supernatant, 351 g/liter solid ammonium sulfate was added and kept at
4°C for 30 min under stirring. The suspension was sedimented at
3000g for 20 min (4°C). The resulting pellet was
resuspended in buffer A, and five volumes of ethanol were added. The
sample was stirred for 30 min (4°C). The suspension was centrifuged
for 30 min at 27,000g (4°C). The resulting pellet was
extracted with buffer A and sedimented at 27,000g for 20 min (4°C). The supernatant was kept. The pellet was re-extracted with buffer A and sedimented again at 27,000g for 20 min (4°C).
Supernatants were combined and dialyzed against a 10-fold volume of
buffer A containing 10% glycerol. The dialyzed sample was applied to a
column containing heparin-Sepharose equilibrated in buffer A. Fractions
of 3 ml were collected in the flow through (peak 1, PP 2A) and in a
linear gradient from 0 to 0.5 M NaCl (peak 2, PP 1) in buffer A. Aliquots of fractions obtained were used for determination of
phosphatase activity.
Phosphatase Assay.
Phosphatase activity was determined as
described previously (Neumann et al., 1993
; Knapp et al., 1998
) using
[32P]phosphorylase a as substrate.
The reaction was started by adding aliquots of homogenates or aliquots
of peak fractions. Reaction was stopped by addition of 50%
trichloroacetic acid. Precipitated protein was sedimented by
centrifugation, and the supernatant was counted in a liquid
scintillation counter.
Protein Determination
Protein was measured according to the method of Bradford (1976)
.
Chemicals
Medium 199, amphotericin B, benzamidine, leupeptin, phenylmethylsulfonyl fluoride, and cantharidin were purchased from Sigma; L-glutamine and penicillin/streptomycin solution were purchased from Serva (Heidelberg, Germany) and Life Technologies, Inc. (Gaithersburg, MD), respectively. Gentamicin and trypsine/EDTA solution were obtained from Boehringer Mannheim (Mannheim, Germany). Fetal calf serum was obtained from Eurobio (Raunheim, Germany) and Boehringer Mannheim. Indo 1/AM and pluronic were purchased from Molecular Probes (Leiden, the Netherlands). Antibodies against PP 1 (rabbit polyclonal IgG, lot 12641) and PP 2A (rabbit polyclonal IgG, lot 13949) were obtained from BIOMOL Research Laboratories (Plymouth Meeting, PA). The antibody directed against the regulatory light chains of myosin (mouse monoclonal antimyosin light chains, 20 kDa; clone MY-21) and the antibody to factor VIII-related antigen were obtained from Sigma. All other chemicals used were of analytical or best commercially grade available.
Statistics
Results are expressed as mean ± S.E.M. Significance was estimated by Student's t test for paired and unpaired observations as appropriate. A P value <.05 was considered to be significant.
| |
Results |
|---|
|
|
|---|
Effects of Cantharidin on Albumin Flux.
To assess the effect
of cantharidin on endothelial function, we studied the permeability of
albumin in bovine endothelial monolayers. In the present study, albumin
permeability was continuously monitored by determining the flux of
labeled albumin across endothelial monolayers. Under control
conditions, mean albumin flux set at 100% in Fig.
1 was 3.9 ± 0.4 × 10
13 mol/(s × cm2)
corresponding to permeability coefficient of 6.5 ± 0.6 × 10
6 cm/s. Albumin flux of untreated aortic
endothelial monolayers was constant during the entire period of
observation.
|
Cytosolic Calcium Concentrations
([Ca2+]i).
To determine the effect of
cantharidin on bovine aortic endothelial
[Ca2+]i, we exposed Indo
1/AM-loaded monolayers of endothelial cells to 100 µM cantharidin for
30 min. Cantharidin did not affect
[Ca2+]i within 30 min
(94.4% ± 1.7% of predrug value, n = 3). We obtained similar results in control cells treated with an appropriate amount of
the solvent DMSO (96.3% ± 0.3% of predrug value, n = 3). However, the cells responded to 10 µM ATP at the end of the
incubation period with a rapid increase in
[Ca2+]i (151.8% ± 30.6% of predrug value, n = 3). Furthermore, 0.1 µM
bradykinin rapidly elevated free calcium levels (267.6% ± 78.4% of
predrug value, n = 3), indicating that the cells
respond to an adequate stimulus (Himmel et al., 1994
). Thus,
cantharidin did not affect
[Ca2+]i in bovine aortic
endothelial cells.
Protein Phosphorylation in Bovine Aortic Endothelial Cells.
We
studied the effects of cantharidin on protein phosphorylation in
32P-labeled intact bovine aortic endothelial
cells. For comparison, we used okadaic acid, a more potent and
selective inhibitor of phosphatase activity (Honkanen, 1993
; Neumann et
al., 1995
; Knapp et al., 1998
). Both cantharidin and okadaic acid
increased the phosphorylation state of various endothelial proteins in
a concentration-dependent manner. A representative autoradiogram for
cantharidin is depicted in Fig. 2.
Specifically, cantharidin and okadaic acid increased the
phosphorylation state of a protein tentatively identified as the
regulatory light chains of myosin (MLC20) based
on immunoblot analysis (Fig. 3). The
quantitative effects of cantharidin and okadaic acid on
MLC20 phosphorylation are depicted in Fig.
4. Of note, we detected numerous
additional phosphoproteins (Fig. 2) but did not address their identity
in this study.
|
|
|
Immunological Identification of PPs Type 1 (PP 1
) and Type 2A
(PP 2A) Catalytic Subunits.
We subjected extracts of bovine aortic
endothelial cells to gel electrophoresis and transferred separated
proteins to nitrocellulose membranes. After incubating these blots with
antibodies raised against the catalytic subunits of PP 1
and PP 2A
(Fig. 5), we detected prominent bands at
the expected molecular weight of about 36 kDa, indicating the presence
of catalytic subunits of PP 1
and PP 2A
/
in these cells. Next,
we extended our study to the mRNA level by performing Northern blot
experiments.
|
Northern Blots.
We isolated total RNA from bovine aortic
endothelial cells. After separation by agarose electrophoresis and
hybridization on membranes with specific DNA probes, we detected
transcripts coding for PP 1
, PP 1
, and PP 2A
at the expected
sizes of about 1.8 kb, 3.2 kb, and 2.0 kb, respectively, with probes
based on rat sequences (Fig. 6). We did
not detect specific signals for PP 1
and PP 2A
in bovine aortic
endothelial cells under our experimental conditions.
|
PP Activity in Homogenates of Bovine Aortic Endothelial Cells.
Cantharidin inhibited phosphatase activity in homogenates from bovine
aortic endothelial cells with an IC50 value of
about 200 nM as reported before (Knapp et al., 1997
). Here, we also studied okadaic acid, a structurally unrelated potent inhibitor of
phosphatase activity in many tissues (Honkanen, 1993
; Neumann et al.,
1995
; Verin et al., 1995
; Knapp et al., 1998
) for comparison. Okadaic
acid inhibited phosphatase activity in homogenates from bovine aortic
endothelial cells in a concentration-dependent fashion with an
IC50 value of about 3 nM (n = 3).
Thus, cantharidin is about 70-fold less potent but equieffective as
okadaic acid.
Effects of Cantharidin and Okadaic Acid on Separated Phosphatase
Activities.
We separated catalytic subunits of PP 1 and PP 2A from
bovine aortic endothelial cells by column chromatography (Fig.
7). The first peak of activity
corresponds most likely to PP 2A and the second peak to PP 1. Cantharidin inhibited the activities of PP 1 and PP 2A with
IC50 values of about 3 µM and 30 nM,
respectively (Fig. 8A). Okadaic acid was
equieffective as
but more potent than
cantharidin, with
IC50 values of about 30 nM for PP 1 and 0.1 nM
for PP 2A (Fig. 8B).
|
|
| |
Discussion |
|---|
|
|
|---|
The main findings of the present study are that cantharidin can increase the phosphorylation state of proteins in bovine aortic endothelial cells, can inhibit the activity of PPs type 1 (PP 1) and type 2A (PP 2A) of endothelial cells, and can alter endothelial barrier function.
In this study, we show the presence of PP 1 and PP 2A in bovine aortic
endothelial cells by several lines of evidence. First, the enzymatic
activity of PP 1 and PP 2A was present in homogenates from aortic
endothelial cells. We could separate the activities of the catalytic
subunits of PP 1 and PP 2A from the regulatory subunits by means of
ethanol precipitation and then separate PP 1 and PP 2A from each other
by affinity chromatography on heparin Sepharose. This methodology is
similar to previous separation procedures in rabbit liver (Erdödi
et al., 1985
), guinea pig cardiomyocytes (Herzig et al., 1995
), guinea
pig heart (Neumann et al., 1995
), human heart (Neumann et al., 1997
),
and bovine coronary arteries and bovine smooth muscle cells (Knapp et
al., 1998
).
Second, we could identify the catalytic subunits of PP 1 and PP 2A in
aortic endothelial cells immunologically by a method used before in
bovine smooth muscle cells (Knapp et al., 1998
). Others have identified
catalytic subunits of PP 1 and PP 2A in bovine pulmonary endothelial
cells and human umbilical vein endothelial cells by immunoblot analysis
(Verin et al., 1995
).
Third, we identified the expression of PP 1
, PP 1
, and PP 2A
by Northern blot analysis using subtype-specific probes. These catalytic subunits are also present in bovine coronary arteries, isolated smooth muscle cells, and myocardium (Knapp et al., 1998
). Others have shown the expression of catalytic subunits of PP 1 in human
umbilical vein endothelial cells using PCR (Shasby et al., 1997
). Taken
together, our data demonstrate that PP 1 and PP 2A are present on mRNA
and protein level in bovine aortic endothelial cells. We conclude that
PP 1
, PP 1
, and PP 2A
are ubiquitous in the cardiovascular system.
Cantharidin is a known specific inhibitor of PP 1 and PP 2A (Honkanen,
1993
; Neumann et al., 1995
; Knapp et al., 1997
, 1998
). Although
structurally unrelated to other PP inhibitors, cantharidin shares
functional effects with other PP inhibitors like okadaic acid (Kodama
et al., 1986
; Takai et al., 1987
). In the past and in this present
study, we have used experimental conditions where the sum of PP 1 and
PP 2A activity is measured in homogenates. We confined our interest to
PP 1 and PP 2A because they comprise more than 90% of PP activity in
eukaryotic cells (DePaoli-Roach et al., 1994
). Cantharidin inhibited PP
activity in homogenates of bovine aortic endothelial cells with a
similar potency as in homogenates from guinea pig cardiomyocytes, human
cardiac muscle, bovine cardiac muscle, bovine coronary arteries, bovine
aortic smooth muscle cells, and bovine coronary artery smooth muscle cells (Linck et al., 1996
; Neumann et al., 1995
; Knapp et al., 1997
,
1998
). In all PP measurements in homogenates, cantharidin was less
potent than okadaic acid.
Cantharidin inhibited activity of PP 1 less potently than the activity
of PP 2A in several tissues. This holds true for PP 1 and PP 2A
purified from bovine aortic endothelial cells (present study), bovine
vascular smooth muscle (Knapp et al., 1998
), and guinea pig heart
(Neumann et al., 1995
). Moreover, cantharidin is consistently less
potent than okadaic acid to inhibit purified PP 1 and PP 2A activity.
For instance, cantharidin and okadaic acid inhibit the activity of PP 1 from guinea pig heart with IC50 values of 2.70 µM and 120 nM and of PP 2A with IC50 values of 0.13 µM and 0.7 nM, respectively.
How do PPs affect endothelial function? We studied the effect of PP
inhibition by cantharidin on endothelial permeability by using a well
characterized technique, namely albumin flux (Siflinger-Birnboim et
al., 1987
; Garcia et al., 1996
; Hempel et al., 1996
). Cantharidin elevated the albumin flux through aortic endothelial cell monolayers. To the best of our knowledge, this has not been reported before. This
enhanced permeability is a clear indication that PP could play an
important role in the barrier function of endothelial cells. It is
possible that the enhanced flux is the result of phosphorylation of
regulatory proteins in these cells. Others have noted before that
thrombin enhances the permeability of endothelial cells (Garcia et al.,
1995
). The authors attributed enhanced permeability to
MLC20 phosphorylation and contraction of
endothelial cells. Consistent with the assumption that cantharidin is
able to permeate intact cell membranes, cantharidin increased
MLC20 phosphorylation in
32P-labeled aortic endothelial cells. It is
noteworthy that we required higher concentrations of cantharidin than
of okadaic acid to elevate protein phosphorylation in these cells.
These observations strongly support the view that cantharidin acts
mainly, if not exclusively, by inhibition of PP 1 and PP 2A activities.
Furthermore, cantharidin did not increase cytosolic
Ca2+ in aortic endothelial cells (this study) and
vascular smooth muscle cells (Knapp et al., 1998
). Thus, it seems
unlikely that cantharidin enhances MLC20
phosphorylation by activating
Ca2+/calmodulin-dependent myosin light chain kinase.
Interestingly, indirect evidence indicates that thrombin acts at least
in part by inhibition of PP activity in endothelial cells (Shasby et
al., 1997
). However, a caveat is in order. Others used nonradioisotopic
methods and noted that histamine, thrombin, and PP inhibitors could
elevate MLC20 phosphorylation (Verin et al.,
1995
; Shasby et al., 1997
). The present work, using the more powerful
method of metabolic labeling of endothelial cells with [32P]orthophosphate, clearly indicates that
numerous proteins in addition to MLC20 are also
phosphorylated in the presence of a PP inhibitor. Hence, the enhanced
permeability in endothelial cells could involve other substrates
in addition to MLC20 (for review, see
DePaoliRoach et al., 1994
; and Lum and Malik, 1994
). It has
not been reported before that PP inhibition by cantharidin stimulates
the permeability of bovine aortic endothelial cells. Although both PP 1 and PP 2A are known to dephosphorylate MLC20 (Haeberle et al., 1985
; Shirazi et al., 1994
), it has been hypothesized that PP 1 is the most important PP that regulates the phosphorylation state of MLC20 in endothelial cells. This
conclusion was based on the observation that 100 nM okadaic acid did
not affect MLC20 phosphorylation (Verin et al.,
1995
). Likewise, we noted that at least 10 µM okadaic acid is
necessary to stimulate MLC20 phosphorylation (Fig. 4). Hence, our data indicate that MLC20
phosphorylation in aortic endothelial cells like in pulmonary artery
endothelial cells (Verin et al., 1995
) probably involves mainly PP 1.
In summary, we present evidence that PP 1 and PP 2A are involved in the regulation of aortic endothelial permeability. This conclusion is based on the fact that inhibition of these PPs by cantharidin increases macromolecule permeability and at the same time increases the phosphorylation state of endothelial regulatory proteins.
| |
Acknowledgments |
|---|
The skillful technical assistance of Insa Post, Cordula Vischedyk, and Elena Herz is gratefully acknowledged.
| |
Footnotes |
|---|
Accepted for publication January 22, 1999.
Received for publication October 21, 1998.
1 This work was supported by the Deutsche Forschungsgemeinschaft and the Konferenz der Deutschen Akademien der Wissenschaften
Send reprint requests to: Dr. Jörg Knapp, Institut
für Pharmakologie und Toxikologie, Westfälische
Wilhelms-Universität Münster, Domagkstra
e 12, D-48129
Münster, Federal Republic of Germany. E-mail:
jknapp{at}unimuenster.de
| |
Abbreviations |
|---|
PP, protein phosphatase; MLC20, regulatory light chains of myosin (20 kDa); MLCK, myosin light chain kinase; DMSO, dimethyl sulfoxide; PCR, polymerase chain reaction.
| |
References |
|---|
|
|
|---|
catalytic subunit.
Nucleic Acids Res
16:
11366
-adrenoceptor-mediated vasorelaxation.
Br J Pharmacol
120:
421-428[Medline].
catalytic subunit.
Nucleic Acids Res
16:
11365This article has been cited by other articles:
![]() |
G. P. van Nieuw Amerongen, R. J. P. Musters, E. C. Eringa, P. Sipkema, and V. W. M. van Hinsbergh Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1234 - C1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.P. van Nieuw Amerongen, C.M.L. Beckers, I.D. Achekar, S. Zeeman, R.J.P. Musters, and V.W.M. van Hinsbergh Involvement of Rho Kinase in Endothelial Barrier Maintenance Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2332 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Csortos, I. Kolosova, and A. D. Verin Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.V. Hartel, C.W. Rodewald, M. Aslam, D. Gunduz, L. Hafer, J. Neumann, H.M. Piper, and T. Noll Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells Cardiovasc Res, June 1, 2007; 74(3): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Noll, M. Schafer, U. Schavier-Schmitz, and H. M. Piper ATP induces dephosphorylation of myosin light chain in endothelial cells Am J Physiol Cell Physiol, September 1, 2000; 279(3): C717 - C723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Knapp, P. Bokník, B. Linck, H. Lüss, F. U. Müller, L. Petertönjes, W. Schmitz, and J. Neumann Cantharidin Enhances Norepinephrine-Induced Vasoconstriction in an Endothelium-Dependent Fashion J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 620 - 626. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||